Ziming Wang
Ziming Wang publishes mostly in Surgery, Oncology and Molecular Biology, on topics such as Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers and CAR-T cell therapy research.
- World rank
- #1,996,010 of 7,710,434 ranked researchers
- Rank in China
- #307,148 of 978,568
- Works
- 63
- Citations
- 637
- Citations per work
- 10.1
What does Ziming Wang research?
Ziming Wang's work is mostly in Medicine (38%), Biochemistry, Genetics and Molecular Biology (18%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else2538.9%
- Health Sciences2437.6%
- Medicine2437.6%
- Life Sciences1523.5%
- 1Surgery17% of their works
- 2Oncology15% of their works
- 3Molecular Biology12% of their works
- 4Pulmonary and Respiratory Medicine6% of their works
- 5Cancer Research6% of their works
- 6Immunology6% of their works
Research topics
Which keywords describe Ziming Wang's research?
The keywords of their largest research topics: Cancer Immunotherapy, Tumor Microenvironment, Complications, Clinical Practice Guidelines, Dendritic Cells, Gene Expression, Immune Checkpoint Blockade and Immunity.
- Breast Tumours
- Osteosarcoma
- Hip Fracture
- Cancer
- Chimeric Antigen Receptor
- Arthroplasty
- Immunity
- Gene Expression
- Clinical Practice Guidelines
- Tumor Microenvironment
- Cancer Immunotherapy
- Complications
- Dendritic Cells
- Immune Checkpoint Blockade
- PD-1 and PD-L1
- CAR T Cells
- Total Knee Replacement
- Ferroptosis
- Mortality
- Soft Tissue Sarcoma
- Treatment Response
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Cancer Immunotherapy122 topics
- Tumor Microenvironment112 topics
- Complications92 topics
- Clinical Practice Guidelines72 topics
- Dendritic Cells71 topic
- Gene Expression72 topics
- Immune Checkpoint Blockade71 topic
- Immunity71 topic
- PD-1 and PD-L171 topic
- Arthroplasty51 topic
- CAR T Cells51 topic
- Chimeric Antigen Receptor51 topic
- Total Knee Replacement51 topic
- Cancer41 topic
- Ferroptosis41 topic
- Hip Fracture41 topic
- Mortality41 topic
- Osteosarcoma41 topic
- Soft Tissue Sarcoma41 topic
- Breast Tumours31 topic
- Treatment Response31 topic
Where does Ziming Wang work?
Ziming Wang's main affiliation in the publication record is Daping Hospital, China.
How many publications and citations does Ziming Wang have?
OpenAlex counts 63 works and 637 citations for Ziming Wang, an h-index of 13, ranking #1,996,010 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Ziming Wang
- ziming-wang-xiamen-university
- ziming-wang-chinese-academy-of-sciences
- ziming-wang-second-affiliated-hospital-of-xian-jiaotong-university
- ziming-wang-jilin-university
- ziming-wang-chinese-academy-of-sciences-china
- ziming-wang-beijing-university-of-technology
- ziming-wang-army-medical-university
- ziming-wang-chinese-academy-of-sciences-china-2
- ziming-wang-dalian-university-of-technology
- ziming-wang-charite-universitatsmedizin-berlin
- ziming-wang-southwest-university
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ziming Wang. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.